JP2005504538A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504538A5 JP2005504538A5 JP2003532628A JP2003532628A JP2005504538A5 JP 2005504538 A5 JP2005504538 A5 JP 2005504538A5 JP 2003532628 A JP2003532628 A JP 2003532628A JP 2003532628 A JP2003532628 A JP 2003532628A JP 2005504538 A5 JP2005504538 A5 JP 2005504538A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- compound
- identifying
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims 35
- 229920001184 polypeptide Polymers 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 21
- 238000000034 method Methods 0.000 claims 18
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 230000027455 binding Effects 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 208000018706 hematopoietic system disease Diseases 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 210000000130 stem cell Anatomy 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000003321 amplification Effects 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 238000012875 competitive assay Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 150000003384 small molecules Chemical class 0.000 claims 2
- 238000003158 yeast two-hybrid assay Methods 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 1
- 230000011132 hemopoiesis Effects 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32573701P | 2001-09-28 | 2001-09-28 | |
| PCT/US2002/030817 WO2003029410A2 (en) | 2001-09-28 | 2002-09-27 | METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504538A JP2005504538A (ja) | 2005-02-17 |
| JP2005504538A5 true JP2005504538A5 (enExample) | 2006-01-05 |
Family
ID=23269216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532628A Pending JP2005504538A (ja) | 2001-09-28 | 2002-09-27 | 新規ヒトＮａ／Ｃａ交換体ファミリーメンバー６９０３９を使用する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7045505B2 (enExample) |
| EP (1) | EP1430144A4 (enExample) |
| JP (1) | JP2005504538A (enExample) |
| AU (1) | AU2002330127A1 (enExample) |
| WO (1) | WO2003029410A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007138066A2 (en) * | 2006-05-31 | 2007-12-06 | Unilever N.V. | Method of screening for compounds that alter skin and/or hair pigmentation |
| US20100249373A1 (en) * | 2007-11-27 | 2010-09-30 | Richard Martin Ogborne | Screening methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6612700A (en) | 1999-07-29 | 2001-02-19 | Genaissance Pharmaceuticals, Inc. | Drug target isogenes: polymorphisms in the solute carrier family 6 neurotransmitter transporter, serotonin , member gene |
| EP1282706A2 (en) | 2000-05-02 | 2003-02-12 | MERCK PATENT GmbH | Natrium-calcium exchanger protein |
| US20020119518A1 (en) | 2000-10-17 | 2002-08-29 | Merkulov Gennady V. | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| WO2002046415A2 (en) * | 2000-12-08 | 2002-06-13 | Incyte Genomics, Inc. | Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| WO2002059316A2 (en) | 2001-01-23 | 2002-08-01 | Lexicon Genetics Incorporated | Human ion exchanger proteins and polynucleotides encoding the same |
| US20030185815A1 (en) | 2001-04-03 | 2003-10-02 | Muralidhara Padigaru | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
-
2002
- 2002-09-27 JP JP2003532628A patent/JP2005504538A/ja active Pending
- 2002-09-27 AU AU2002330127A patent/AU2002330127A1/en not_active Abandoned
- 2002-09-27 US US10/256,537 patent/US7045505B2/en not_active Expired - Fee Related
- 2002-09-27 WO PCT/US2002/030817 patent/WO2003029410A2/en not_active Ceased
- 2002-09-27 EP EP02766389A patent/EP1430144A4/en not_active Withdrawn